World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03292744
Date of registration: 21/09/2017
Prospective Registration: No
Primary sponsor: Indonesia University
Public title: Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly
Scientific title: Effect of Alfacalcidol Supplementation to Respiratory Infection, Inflammatory Markers and CD4/CD8 Ratio of Indonesian Elderly
Date of first enrolment: January 10, 2017
Target sample size: 110
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03292744
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Indonesia
Contacts
Name:     Aulia Rizka, MD
Address: 
Telephone: +628125265600
Email: dr.auliarizka@yahoo.co.id
Affiliation: 
Name:     Aulia Rizka, MD
Address: 
Telephone:
Email:
Affiliation:  Universitas Indonesia / Cipto Mangunkusumo Hospital
Name:     Aulia Rizka, MD
Address: 
Telephone: +628125265600
Email: dr.auliarizka@yahoo.co.id
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Elderly age more than 60

- Willing to join research

Exclusion Criteria:

- In acute infection

- Using NSAID or steroid

- Liver failure

- Hypercalcemia



Age minimum: 60 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Elderly Infection
Frail Elderly Syndrome
Intervention(s)
Drug: Alfacalcidol
Primary Outcome(s)
upper respiratory tract infection incidence [Time Frame: 90 days]
lower respiratory tract infection incidence [Time Frame: 90 days]
Secondary Outcome(s)
T cell subset [Time Frame: day 90]
antibiotic use [Time Frame: 90 days]
inflammatory markers [Time Frame: day 90]
Secondary ID(s)
VitaminDIndonesia
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history